Forbes & Company share price
You have to be logged in to add this to Watchlist.- ₹285.00(2.11%)March 18, 2025 12:40:00 PM IST
- NSE
- BSE
- Vol : 6.39K (NSE + BSE)Last 20 day avg : 28.19 K
Forbes & Company is trading 2.11% upper at Rs 285.00 as compared to its last closing price. Forbes & Company has been trading in the price range of 292.00 & 280.50. Forbes & Company has given -40.33% in this year & -4.09% in the last 5 days. Forbes & Company has TTM P/E ratio 36.28 as compared to the sector P/E of 17.01.The company posted a net profit of 9.50 Crores in its last quarter.Listed peers of Forbes & Company include Dr. Agarwal's Eye Hospital (-1.07%), Kerala Ayurveda (3.76%), Forbes & Company (2.11%).The Mutual Fund holding in Forbes & Company was at 0.49% in 31 Dec 2021. The MF holding has - from the last quarter. The FII holding in Forbes & Company was at 10.16% in 31 Dec 2024. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on Mar 18, 2025, 07:25 AM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BLower than historical values2.57The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values21.64Price-to-earnings ratio based on trailing 12-month earnings
- BetaLow volatility0.77Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.06The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable- The company's revenue grew in December quarter by 238.35% from Rs 40.23 crore to Rs 11.89 crore, year-on-year
- The company has grown its December quarter profit by 141.73% from Rs 3.93 crore to Rs 9.50 crore, year-on-year
- The debt to equity of the company is lower than the industry median
- Company can comfortably pay off its interest obligations with its earnings
- R1
- 366.48
- R2
- 410.97
- R3
- 462.03
- S1
- 270.93
- S2
- 219.87
- S3
- 175.38
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Dr. Agarwal's Eye Hospital | Neutral | 4,290.00 | -1.07 | 2,029.68 | 44.58 | 13.2 | 0.11 | 157.84 |
| Kerala Ayurveda | Bullish | 374.00 | 3.76 | 450.01 | - | 13.48 | - | 184.73 |
| Forbes & Company | Bearish | 285.00 | 2.11 | 367.61 | 64.37 | 2.6 | - | 3.57 |
| Aashka Hospitals | Bearish | 98.00 | -4.76 | 229.32 | 104.06 | 2.55 | - | 8.59 |
| Lotus Eye Hospital & Institute | Bearish | 56.99 | 0.28 | 118.52 | 40.77 | 2 | - | 1.16 |
Pledged found - Promoter(s) have pledged 98.25% of shares.- Pledging Flat - Promoter(s) pledging has not increased in last quarter.
- Promoter(s) holds a high stake in the company at 73.85%
- FIIs are invested in this company
- FIIs holding has decreased by 1.14 percentage points from previous quarter
- Mutual Funds are not invested in this company.
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-02-11 | Quarterly Results |
| 2024-10-28 | Quarterly Results |
| 2024-08-02 | Quarterly Results |
| 2024-05-29 | Audited Results |
| 2024-01-25 | Quarterly Results |
- IndustryHealthcare Facilities
- ISININE518A01013
- BSE Code502865
- NSE Code
Forbes & Company is trading at 285.00 as on Tue Mar 18 2025 07:10:00. This is 2.11% upper as compared to its previous closing price of 279.10.
The market capitalization of Forbes & Company is 367.61 Cr as on Tue Mar 18 2025 07:10:00.
The 52 wk high for Forbes & Company is 796.25 whereas the 52 wk low is 264.35
Forbes & Company can be analyzed on the following key metrics -
- TTM P/E: 36.28
- Sector P/E: 17.01
- Dividend Yield: 0.00%
- D/E ratio: -
Forbes & Company reported a net profit of -4.46 Cr in 2024.
The Mutual Fund Shareholding was 0.49% at the end of 31 Dec 2021.